BRAFV600E Mutation Associated With Non–Radioiodine-Avid Status in Distant Metastatic Papillary Thyroid Carcinoma

Abstract

BRAF mutation in primary tumor might be a promising molecular marker to predict the status of I uptake in distal metastases.